Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Change in Accured Expenses (2016 - 2025)

Cavitation Technologies' Change in Accured Expenses history spans 16 years, with the latest figure at $45000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 1600.0% year-over-year to $45000.0; the TTM value through Dec 2025 reached $11000.0, up 139.29%, while the annual FY2024 figure was $9000.0, N/A changed from the prior year.
  • Change in Accured Expenses for Q4 2025 was $45000.0 at Cavitation Technologies, up from $21000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $68000.0 in Q4 2023 and bottomed at -$124000.0 in Q2 2024.
  • The 5-year median for Change in Accured Expenses is $6000.0 (2023), against an average of $4947.4.
  • The largest annual shift saw Change in Accured Expenses plummeted 2166.67% in 2024 before it surged 1600.0% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$14000.0 in 2021, then soared by 307.14% to $29000.0 in 2022, then skyrocketed by 134.48% to $68000.0 in 2023, then tumbled by 104.41% to -$3000.0 in 2024, then soared by 1600.0% to $45000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVAT's Change in Accured Expenses are $45000.0 (Q4 2025), $21000.0 (Q3 2025), and -$48000.0 (Q2 2025).